Theriva Biologics, Inc. Quarterly Contract with Customer, Liability, Current in USD from Q3 2023 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.
Summary
Theriva Biologics, Inc. quarterly Contract with Customer, Liability, Current history and growth rate from Q3 2023 to Q4 2023.
  • Theriva Biologics, Inc. Contract with Customer, Liability, Current for the quarter ending December 31, 2023 was $906K.
Contract with Customer, Liability, Current, Quarterly (USD)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $906K Dec 31, 2023 10-K 2024-03-25
Q3 2023 $525K Sep 30, 2023 10-Q 2023-11-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.